ABVC BIOPHARMA, INC. — Director's Dealing 2021

Nov 15, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABVC BIOPHARMA, INC. (ABVC)
CIK: 0001173313
Period of Report: 2021-08-02

Reporting Person: Jiang Tsung Shann (Director, CSO and Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12103971	Indirect

Footnotes

F1: Dr. Tsung-Shann Jiang holds 8,296,968 shares of common stock through his ownership in YuanGene Corporation, 11,603 shares of the Company's common stock through BioLite, 19,609 shares through Rgene Corporation, 143,264 shares through BioFirst, 674,723 shares through Lion Arts, 509,877 shares through LionGene, 8,850 shares through Genepro Investment, 213,120 shares through Keypoint, 64,215 shares through Shu-Ling Chiang, and the rest of 2,161,742 shares through direct ownership. YuanGene Corporation is a company wholly-owned by Lion Arts, which is owned by Shu-Ling Chiang (80%) and Dr. Tsung-Shann Jiang (20%); however, YuanGene appointed Eugene Jiang to have sole voting control over the shares held by YuanGene.